|
2025-01-17 |
2025-01-16 |
V
Vente
|
Nighan Warren JR
SVP Quality and Regulatory
Dirigeant
|
4 060
-8.8%
12,31
49 979 USD
|
4 060
-8.8%
|
12,31
|
49 979 USD
|
|
|
2024-10-10 |
2024-10-10 |
A
Achat
|
Nighan Warren JR
SVP Quality and Regulatory
Dirigeant
|
100
+0.2%
6,08
608 USD
|
100
+0.2%
|
6,08
|
608 USD
|
|
|
2024-10-08 |
2024-10-08 |
A
Achat
|
Trowbridge Stephen A
EVP and CFO
Dirigeant
|
1 700
+1.0%
5,86
9 962 USD
|
1 700
+1.0%
|
5,86
|
9 962 USD
|
|
|
2024-10-10 |
2024-10-07 |
A
Achat
|
Nighan Warren JR
SVP Quality and Regulatory
Dirigeant
|
768
+1.7%
6,09
4 677 USD
|
768
+1.7%
|
6,09
|
4 677 USD
|
|
|
2024-10-08 |
2024-10-07 |
A
Achat
|
Clemmer James C
President and CEO
Administrateur exécutif
|
20 000
+3.0%
6,03
120 600 USD
|
20 000
+3.0%
|
6,03
|
120 600 USD
|
|
|
2024-04-08 |
2024-04-08 |
A
Achat
|
Clemmer James C
President and CEO
Administrateur exécutif
|
10 000
+1.9%
6,70
67 000 USD
|
10 000
+1.9%
|
6,70
|
67 000 USD
|
|
|
2023-02-01 |
2023-01-31 |
V
Vente
|
Helsel Dave
SVP Global Operations and R&D
Dirigeant
|
4 633
-19.4%
12,95
59 997 USD
|
4 633
-19.4%
|
12,95
|
59 997 USD
|
|
|
2022-10-12 |
2022-10-12 |
A
Achat
|
Trowbridge Stephen A
EVP and CFO
Dirigeant
|
1 083
+1.2%
13,82
14 967 USD
|
1 083
+1.2%
|
13,82
|
14 967 USD
|
|
|
2022-10-11 |
2022-10-10 |
A
Achat
|
Clemmer James C
President and CEO
Administrateur exécutif
|
10 000
+2.3%
15,00
150 000 USD
|
10 000
+2.3%
|
15,00
|
150 000 USD
|
|
|
2022-08-01 |
2022-07-29 |
V
Vente
|
Helsel Dave
SVP Global Operations and R&D
Dirigeant
|
5 000
-17.3%
22,44
112 200 USD
|
5 000
-17.3%
|
22,44
|
112 200 USD
|
|
|
2022-05-02 |
2022-04-28 |
V
Vente
|
Helsel Dave
SVP Global Operations and R&D
Dirigeant
|
3 513
-13.3%
22,44
78 832 USD
|
3 513
-13.3%
|
22,44
|
78 832 USD
|
|
|
2022-04-13 |
2022-04-12 |
V
Vente
|
JOHNSON WESLEY
Administrateur non-exécutif
|
1 299
-1.6%
23,26
30 215 USD
|
1 299
-1.6%
|
23,26
|
30 215 USD
|
|
|
2022-04-13 |
2022-04-11 |
V
Vente
|
JOHNSON WESLEY
Administrateur non-exécutif
|
6 201
-7.2%
23,00
142 623 USD
|
6 201
-7.2%
|
23,00
|
142 623 USD
|
|
|
2022-01-12 |
2022-01-12 |
A
Achat
|
Trowbridge Stephen A
EVP and CFO
Dirigeant
|
1 000
+1.3%
22,64
22 640 USD
|
1 000
+1.3%
|
22,64
|
22 640 USD
|
|
|
2022-01-12 |
2022-01-11 |
A
Achat
|
Clemmer James C
President and CEO
Administrateur exécutif
|
10 000
+2.6%
22,84
228 400 USD
|
10 000
+2.6%
|
22,84
|
228 400 USD
|
|
|
2021-10-21 |
2021-10-20 |
V
Vente
|
Helsel Dave
SVP Global Operations and R&D
Dirigeant
|
3 494
-11.7%
27,97
97 727 USD
|
3 494
-11.7%
|
27,97
|
97 727 USD
|
|
|
2021-10-18 |
2021-10-15 |
V
Vente
|
Centea Scott
Sr. VP/GM, Global VIT
Dirigeant
|
12 000
-20.6%
27,92
335 040 USD
|
12 000
-20.6%
|
27,92
|
335 040 USD
|
|
|
2021-10-06 |
2021-10-05 |
V
Vente
|
Campbell Chad Thomas
SVP/GM, Vascular Access
Dirigeant
|
10 748
-25.3%
27,15
291 808 USD
|
10 748
-25.3%
|
27,15
|
291 808 USD
|
|
|
2021-04-15 |
2021-04-14 |
V
Vente
|
Helsel Dave
SVP Global Operations and R&D
Dirigeant
|
3 500
-15.5%
23,93
83 755 USD
|
3 500
-15.5%
|
23,93
|
83 755 USD
|
|
|
2021-01-21 |
2021-01-20 |
V
Vente
|
JOHNSON WESLEY
Administrateur non-exécutif
|
6 500
-7.7%
18,53
120 445 USD
|
6 500
-7.7%
|
18,53
|
120 445 USD
|
|
|
2020-08-12 |
2020-08-11 |
A
Achat
|
Trowbridge Stephen A
EVP and CFO
Dirigeant
|
1 013
+1.7%
9,38
9 502 USD
|
1 013
+1.7%
|
9,38
|
9 502 USD
|
|
|
2020-08-03 |
2020-07-31 |
A
Achat
|
Clemmer James C
President and CEO
Administrateur exécutif
|
40 000
+13.2%
8,26
330 400 USD
|
40 000
+13.2%
|
8,26
|
330 400 USD
|
|
|
2019-10-28 |
2019-10-25 |
A
Achat
|
Clemmer James C
President and CEO
Administrateur exécutif
|
15 000
+6.1%
14,19
212 850 USD
|
15 000
+6.1%
|
14,19
|
212 850 USD
|
|
|
2019-07-18 |
2019-07-16 |
V
Vente
|
Gould Kevin J
|
13 650
-19.8%
21,45
292 793 USD
|
13 650
-19.8%
|
21,45
|
292 793 USD
|
|
|
2018-11-08 |
2018-11-07 |
V
Vente
|
Greiner Michael
EVP and CFO
Dirigeant
|
1 939
-8.6%
21,53
41 747 USD
|
1 939
-8.6%
|
21,53
|
41 747 USD
|
|
|
2017-11-17 |
2017-11-15 |
V
Vente
|
Richard Stark
SVP, GM - Oncology
|
27 409
-56.9%
16,29
446 493 USD
|
27 409
-56.9%
|
16,29
|
446 493 USD
|
|
|
2017-07-25 |
2017-07-24 |
A
Achat
|
REED JAN STERN
Administrateur non-exécutif
|
316
+inf%
16,00
5 056 USD
|
316
+inf%
|
16,00
|
5 056 USD
|
|
|
2017-07-21 |
2017-07-21 |
A
Achat
|
Clemmer James C
President and CEO
Administrateur exécutif
|
5 000
+5.8%
15,79
78 950 USD
|
5 000
+5.8%
|
15,79
|
78 950 USD
|
|
|
2017-07-21 |
2017-07-21 |
A
Achat
|
DONNELLY HOWARD W
Administrateur non-exécutif
|
5 000
+11.7%
15,72
78 600 USD
|
5 000
+11.7%
|
15,72
|
78 600 USD
|
|
|
2017-07-21 |
2017-07-20 |
A
Achat
|
Clemmer James C
President and CEO
Administrateur exécutif
|
20 000
+30.0%
15,64
312 800 USD
|
20 000
+30.0%
|
15,64
|
312 800 USD
|
|
|
2017-04-14 |
2017-04-12 |
V
Vente
|
Avista Capital Partners GP, LLC
Actionnaire important
|
384 184
-50.2%
16,00
6 146 944 USD
|
384 184
-50.2%
|
16,00
|
6 146 944 USD
|
|
|
2017-04-14 |
2017-04-12 |
V
Vente
|
Avista Capital Partners GP, LLC
Actionnaire important
|
508 869
-50.2%
16,00
8 141 904 USD
|
508 869
-50.2%
|
16,00
|
8 141 904 USD
|
|
|
2017-04-14 |
2017-04-12 |
V
Vente
|
Avista Capital Partners GP, LLC
Actionnaire important
|
1 456 947
-50.2%
16,00
23 311 152 USD
|
1 456 947
-50.2%
|
16,00
|
23 311 152 USD
|
|
|
2017-04-14 |
2017-04-12 |
V
Vente
|
Burgstahler David F
Actionnaire important
|
384 184
-50.2%
16,00
6 146 944 USD
|
384 184
-50.2%
|
16,00
|
6 146 944 USD
|
|
|
2017-04-14 |
2017-04-12 |
V
Vente
|
Burgstahler David F
Actionnaire important
|
508 869
-50.2%
16,00
8 141 904 USD
|
508 869
-50.2%
|
16,00
|
8 141 904 USD
|
|
|
2017-04-14 |
2017-04-12 |
V
Vente
|
Burgstahler David F
Actionnaire important
|
1 456 947
-50.2%
16,00
23 311 152 USD
|
1 456 947
-50.2%
|
16,00
|
23 311 152 USD
|
|
|
2016-11-22 |
2016-11-18 |
V
Vente
|
Avista Capital Partners GP, LLC
Actionnaire important
|
541 349
-34.8%
15,68
8 488 352 USD
|
541 349
-34.8%
|
15,68
|
8 488 352 USD
|
|
|
2016-11-22 |
2016-11-18 |
V
Vente
|
Burgstahler David F
Administrateur non-exécutif
Actionnaire important
|
541 349
-34.8%
15,68
8 488 352 USD
|
541 349
-34.8%
|
15,68
|
8 488 352 USD
|
|
|
2016-11-22 |
2016-11-18 |
V
Vente
|
Avista Capital Partners GP, LLC
Actionnaire important
|
1 549 945
-34.8%
15,68
24 303 138 USD
|
1 549 945
-34.8%
|
15,68
|
24 303 138 USD
|
|
|
2016-11-22 |
2016-11-18 |
V
Vente
|
Burgstahler David F
Administrateur non-exécutif
Actionnaire important
|
1 549 945
-34.8%
15,68
24 303 138 USD
|
1 549 945
-34.8%
|
15,68
|
24 303 138 USD
|
|
|
2016-08-05 |
2016-08-05 |
V
Vente
|
Burgstahler David F
Administrateur non-exécutif
Actionnaire important
|
487 214
-23.9%
14,62
7 123 069 USD
|
487 214
-23.9%
|
14,62
|
7 123 069 USD
|
|
|
2016-08-05 |
2016-08-05 |
V
Vente
|
Burgstahler David F
Administrateur non-exécutif
Actionnaire important
|
367 836
-23.9%
14,62
5 377 762 USD
|
367 836
-23.9%
|
14,62
|
5 377 762 USD
|
|
|
2016-08-05 |
2016-08-05 |
V
Vente
|
Avista Capital Partners GP, LLC
Actionnaire important
|
478 214
-23.5%
14,62
6 991 489 USD
|
478 214
-23.5%
|
14,62
|
6 991 489 USD
|
|
|
2016-08-05 |
2016-08-05 |
V
Vente
|
Avista Capital Partners GP, LLC
Actionnaire important
|
367 836
-23.9%
14,62
5 377 762 USD
|
367 836
-23.9%
|
14,62
|
5 377 762 USD
|
|
|
2016-08-05 |
2016-08-05 |
V
Vente
|
Burgstahler David F
Administrateur non-exécutif
Actionnaire important
|
1 394 950
-23.9%
14,62
20 394 169 USD
|
1 394 950
-23.9%
|
14,62
|
20 394 169 USD
|
|
|
2016-08-05 |
2016-08-05 |
V
Vente
|
Avista Capital Partners GP, LLC
Actionnaire important
|
1 394 950
-23.9%
14,62
20 394 169 USD
|
1 394 950
-23.9%
|
14,62
|
20 394 169 USD
|
|
|
2016-05-09 |
2016-05-06 |
V
Vente
|
Greiner Charles R
VP - Global Franchise
Dirigeant
|
3 508
-14.4%
12,31
43 183 USD
|
3 508
-14.4%
|
12,31
|
43 183 USD
|
|
|
2016-04-25 |
2016-04-25 |
V
Vente
|
Trowbridge Stephen A
SVP and General Counsel
Dirigeant
|
2 440
-7.5%
12,18
29 719 USD
|
2 440
-7.5%
|
12,18
|
29 719 USD
|
|
|
2016-04-25 |
2016-04-21 |
V
Vente
|
Trowbridge Stephen A
SVP and General Counsel
Dirigeant
|
10 500
-24.4%
12,33
129 465 USD
|
10 500
-24.4%
|
12,33
|
129 465 USD
|
|
|
2015-02-19 |
2015-02-13 |
V
Vente
|
Richard Stark
SVP, GM - Oncology
Dirigeant
|
18 100
-38.7%
18,53
335 393 USD
|
18 100
-38.7%
|
18,53
|
335 393 USD
|
|
|
2014-10-21 |
2014-10-20 |
V
Vente
|
Greiner Charles R
VP - Global Franchise
Dirigeant
|
3 298
-13.0%
15,63
51 548 USD
|
3 298
-13.0%
|
15,63
|
51 548 USD
|
|
|
2013-11-15 |
2013-11-14 |
V
Vente
|
Greiner Charles R
VP - Global Finance
Dirigeant
|
4 373
-15.9%
15,46
67 611 USD
|
4 373
-15.9%
|
15,46
|
67 611 USD
|
|
|
2013-11-15 |
2013-11-13 |
V
Vente
|
Greiner Charles R
VP - Global Finance
Dirigeant
|
2 392
-9.4%
15,40
36 842 USD
|
2 392
-9.4%
|
15,40
|
36 842 USD
|
|
|
2013-10-21 |
2013-10-18 |
A
Achat
|
BUCCI VINCENT
Administrateur non-exécutif
|
5 000
+6.1%
15,20
75 990 USD
|
5 000
+6.1%
|
15,20
|
75 990 USD
|
|
|
2013-10-21 |
2013-10-17 |
V
Vente
|
DONNELLY HOWARD W
Administrateur non-exécutif
|
20 000
-55.8%
15,06
301 200 USD
|
20 000
-55.8%
|
15,06
|
301 200 USD
|
|
|
2013-07-23 |
2013-07-22 |
A
Achat
|
Gould Kevin J
Administrateur non-exécutif
|
2 700
+32.7%
12,00
32 400 USD
|
2 700
+32.7%
|
12,00
|
32 400 USD
|
|
|
2013-03-13 |
2013-03-12 |
A
Achat
|
BUCCI VINCENT
Administrateur non-exécutif
|
10 000
+333.3%
10,80
108 000 USD
|
10 000
+333.3%
|
10,80
|
108 000 USD
|
|
|
2013-03-13 |
2013-03-12 |
A
Achat
|
BUCCI VINCENT
Administrateur non-exécutif
|
35 000
+1166.7%
10,76
376 600 USD
|
35 000
+1166.7%
|
10,76
|
376 600 USD
|
|
|
2013-03-13 |
2013-03-12 |
A
Achat
|
BUCCI VINCENT
Administrateur non-exécutif
|
40 000
+103.4%
10,78
431 200 USD
|
40 000
+103.4%
|
10,78
|
431 200 USD
|
|
|
2013-03-12 |
2013-03-12 |
A
Achat
|
Meteny Dennis S
Administrateur non-exécutif
|
4 600
+26.5%
10,82
49 772 USD
|
4 600
+26.5%
|
10,82
|
49 772 USD
|
|
|
2013-02-15 |
2013-02-14 |
A
Achat
|
BUCCI VINCENT
Administrateur non-exécutif
|
2 000
+5.5%
12,17
24 332 USD
|
2 000
+5.5%
|
12,17
|
24 332 USD
|
|
|
2013-01-14 |
2013-01-11 |
A
Achat
|
Gould Kevin J
Administrateur non-exécutif
|
2 700
+48.6%
11,58
31 277 USD
|
2 700
+48.6%
|
11,58
|
31 277 USD
|
|
|
2012-11-13 |
2012-11-05 |
A
Achat
|
GOLD JEFFREY
Administrateur non-exécutif
|
1 000
+4.1%
10,56
10 560 USD
|
1 000
+4.1%
|
10,56
|
10 560 USD
|
|
|
2012-11-09 |
2012-11-05 |
V
Vente
|
Richard Stark
SVP, GM - Oncology
Dirigeant
|
3 160
-10.9%
10,36
32 738 USD
|
3 160
-10.9%
|
10,36
|
32 738 USD
|
|
|
2012-07-18 |
2012-07-17 |
A
Achat
|
DEVIVO JOSEPH
President and CEO
Administrateur exécutif
|
2 000
+5.6%
11,67
23 340 USD
|
2 000
+5.6%
|
11,67
|
23 340 USD
|
|
|
2012-05-17 |
2012-05-16 |
V
Vente
|
Richard Stark
SVP, GM - Oncology
Dirigeant
|
2 080
-9.0%
12,42
25 827 USD
|
2 080
-9.0%
|
12,42
|
25 827 USD
|
|
|
2012-04-13 |
2012-04-12 |
A
Achat
|
BUCCI VINCENT
Administrateur non-exécutif
|
4 000
+inf%
11,82
47 280 USD
|
4 000
+inf%
|
11,82
|
47 280 USD
|
|
|
2012-04-12 |
2012-04-11 |
A
Achat
|
Gould Kevin J
Administrateur non-exécutif
|
2 700
+inf%
11,72
31 636 USD
|
2 700
+inf%
|
11,72
|
31 636 USD
|
|
|
2012-04-10 |
2012-04-10 |
A
Achat
|
Kapusta Matthew C
SVP, Business Development
Dirigeant
|
1 000
+6.7%
11,40
11 397 USD
|
1 000
+6.7%
|
11,40
|
11 397 USD
|
|
|
2012-04-10 |
2012-04-09 |
A
Achat
|
BUCCI VINCENT
Administrateur non-exécutif
|
2 000
+6.7%
11,80
23 596 USD
|
2 000
+6.7%
|
11,80
|
23 596 USD
|
|
|
2012-04-10 |
2012-04-09 |
A
Achat
|
DEVIVO JOSEPH
President and CEO
Administrateur exécutif
|
5 000
+16.1%
11,82
59 094 USD
|
5 000
+16.1%
|
11,82
|
59 094 USD
|
|
|
2012-02-21 |
2012-02-21 |
A
Achat
|
BUCCI VINCENT
Administrateur non-exécutif
|
2 000
+7.2%
13,44
26 878 USD
|
2 000
+7.2%
|
13,44
|
26 878 USD
|
|
|
2012-02-15 |
2012-02-15 |
A
Achat
|
BUCCI VINCENT
Administrateur non-exécutif
|
2 000
+7.7%
13,25
26 494 USD
|
2 000
+7.7%
|
13,25
|
26 494 USD
|
|
|
2012-02-15 |
2012-02-13 |
A
Achat
|
BUCCI VINCENT
Administrateur non-exécutif
|
1 000
+4.0%
12,93
12 927 USD
|
1 000
+4.0%
|
12,93
|
12 927 USD
|
|
|
2012-02-13 |
2012-02-13 |
A
Achat
|
DEVIVO JOSEPH
President and CEO
Administrateur exécutif
|
3 000
+10.7%
12,95
38 850 USD
|
3 000
+10.7%
|
12,95
|
38 850 USD
|
|
